Cardiovascular Safety and State-of-the-art Development Issues: Type 2 Diabetes Mellitus Medications, QT, Benefit/Risk Assessment, Arrhythmias, Thrombosis, and Cardiotoxicity

17 - 18 April 2012, Washington, DC, United States

Introduction

Join Industry Experts and Regulators to Improve Your Safety Analysis During Drug Development, Analyze and Mitigate Potential Risks, and Explore New Solutions and Approaches to Developing Safe and Effective Medications, including those to treat Type 2 Diabetes Mellitus.

Event Code:
12009

Useful links

Further event details More information about the event

Venue

Washington Marriott Hotel

Washington Marriott Hotel, Washington, DC, 20037, United States

Organised by

DIA

Contact information

Rachel Minnick
United States of America
2154426131
Contact us by email

Share:

Cardiovascular Safety and State-of-the-art Development Issues: Type 2 Diabetes Mellitus Medications, QT, Benefit/Risk Assessment, Arrhythmias, Thrombosis, and Cardiotoxicity

17 - 18 April 2012, Washington, DC, United States

Useful links

Search

Exclude Online events

Select date range

Start Date

End Date

Location

Subject area

Event type

Share:

Cardiovascular Safety and State-of-the-art Development Issues: Type 2 Diabetes Mellitus Medications, QT, Benefit/Risk Assessment, Arrhythmias, Thrombosis, and Cardiotoxicity

17 - 18 April 2012, Washington, DC, United States

Useful links

Related events

7th International Conference on Nanomaterials Science and Mechanical Engineering

8 July 2025 08:00 - 11 July 2025 18:00, Aveiro, Portugal

Drugging the Multimorbidity Associated with Ageing

17 January 2025 09:30-17:00, London, United Kingdom

Future Labs Live Basel

27 May 2025 09:00 - 28 May 2025 17:00, Basel, Switzerland

21st RSC Nucleic Acids Forum – 2025

11 July 2025 10:00-18:00, London, United Kingdom

Search

Exclude Online events

Select date range

Start Date

End Date

Location

Subject area

Event type